Rafael Holdings, Inc
Advertisement
Rafael Holdings, Inc., based in Newark, NJ, is a fast-growing company focused on developing novel cancer and immune therapies. As a significant investor in clinical stage oncology companies, Rafael Holdings is dedicated to investing in therapeutic assets that address high unmet medical needs and have the potential to improve and extend the lives of patients.
With a portfolio of companies including Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd., Rafael Holdings is actively involved in the discovery and development of oncological therapeutics. The company is currently engaged in multiple clinical programs, including two Phase 3 trials, as it transitions towards becoming a commercial enterprise in the healthcare industry.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Advertisement